P
Philippe Terrier
Researcher at Institut Gustave Roussy
Publications - 158
Citations - 11480
Philippe Terrier is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Sarcoma & Soft tissue sarcoma. The author has an hindex of 55, co-authored 157 publications receiving 10057 citations.
Papers
More filters
Posted ContentDOI
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network
Gonzague de Pinieux,Marie Karanian-Philippe,François Le Loarer,Sophie Le Guellec,Sylvie Chabaud,Philippe Terrier,Corinne Bouvier,Maxime Battistella,Agnès Neuville,Yves-Marie Robin,Jean François Emile,Anne Moreau,Frédérique Larousserie,Agnes Leroux,Nathalie Stock,Marick Laé,Francois Collin,Nicolas Weinbreck,Sébastien Aubert,Florence Mishellany,Céline Charon-Barra,Sabrina Croce,Laurent Doucet,Isabelle Quintin-Rouet,Marie-Christine Chateau,Céline Bazille,Isabelle Valo,Bruno Chetaille,Nicolas Ortonne,Anne Gomez-Brouchet,Philippe Rochaix,Anne de Muret,Jean-Pierre Ghnassia,Lenaig Mescam-Mancini,Nicolas Macagno,Isabelle Birtwisle-Peyrottes,Christophe Delfour,Emilie Angot,Isabelle Pommepuy,Dominique Ranchère-Vince,Claire Chemin-Airiau,Myriam Jean-Denis,Yohan Fayet,Jean-Baptiste Courrèges,Nouria Mesli,Juliane Berchoud,Maud Toulmonde,Antoine Italiano,Axel Le Cesne,Nicolas Penel,Françoise Ducimetière,François Gouin,Jean-Michel Coindre,Jean-Yves Blay,Repps,Resos,French Sarcoma Group-Groupe d’Etude des Tumeurs Osseuses +56 more
TL;DR: This nationwide registry of Sarcoma patients with histology reviewed by sarcoma experts shows that the incidence of sarcomas and TIM is higher than reported, and that tumors with an incidence<106/year have a much lower access to clinical trials.
Journal ArticleDOI
Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors.
Salvatore Romeo,Maria Debiec-Rychter,Martine Van Glabbeke,Heidi van Paassen,Paola Comite,Ronald van Eijk,Jan Oosting,Jaap Verweij,Philippe Terrier,U. Schneider,Raf Sciot,Jean-Yves Blay,Pancras C.W. Hogendoorn +12 more
TL;DR: Impaired p53, p16, BCL2, and CHK2 expression is common in advanced GISTs and cell cycle/apoptosis maintenance is instrumental for optimal response to imatinib.
Journal ArticleDOI
Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases.
TL;DR: Results provide an overview of chromosome imbalances present in MFH, which could be of use for diagnostic purposes and point to various chromosome regions which may harbor genes important for malignant fibrous histiocytomas (MFH) oncogenesis and progression.
Journal ArticleDOI
Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma
Olivier Mir,Julien Domont,Angela Cioffi,Sylvie Bonvalot,B. Boulet,Cécile Le Péchoux,Philippe Terrier,Marc Spielmann,Axel Le Cesne +8 more
TL;DR: Metronomic CPM showed good safety results for this frail population, with promising activity in patients with radiation-induced sarcoma, allowing prolonged home staying and rare treatment discontinuations.
Journal ArticleDOI
Prognostic Factors and Impact of Adjuvant Treatments on Local and Metastatic Relapse of Soft-Tissue Sarcoma Patients in the Competing Risks Setting
Antoine Italiano,Axel Le Cesne,Jean Mendiboure,Jean-Yves Blay,Sophie Piperno-Neumann,Christine Chevreau,Corinne Delcambre,Nicolas Penel,Philippe Terrier,Dominique Ranchère-Vince,Marick Laé,Sophie Le Guellec,Jean-Jacques Michels,Yves Marie Robin,Carine Bellera,Sylvie Bonvalot +15 more
TL;DR: In the medical literature many analyses of outcomes of sarcoma patients were performed without regard to the problem of “competing risks.”